P. Grundt

发表

Effects of selective dopaminergic compounds on a delay-discounting task

Mikhail N. Koffarnus, A. Newman, K. Rice, 2011, Behavioural pharmacology.

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.

M. Nader, A. Newman, P. Grundt, 2005, Journal of medicinal chemistry.

Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2‐(4,5‐Dihydro‐1H‐imidazol‐2‐yl)‐1‐ methyl‐1H‐indole), for the imidazoline2 binding site

E. Robinson, D. Nutt, A. Hudson, 2012, Synapse.

Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys

M. Nader, A. Newman, P. Grundt, 2012, Neuropsychopharmacology.

Dopamine Agonist-Induced Yawning in Rats: A Dopamine D3 Receptor-Mediated Behavior

A. Newman, J. Witkin, J. Woods, 2005, Journal of Pharmacology and Experimental Therapeutics.

Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats

D. Grandy, A. Newman, J. Woods, 2010, Behavioural pharmacology.

The Chemistry of Tryptanthrin and Its Derivatives

P. Grundt, A. Tucker, 2012 .

Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.

J. Lewis, N. Zaveri, L. Toll, 2001, European journal of pharmacology.

N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.

Robert R Luedtke, Peter Grundt, Michelle Taylor, 2009, Journal of medicinal chemistry.

Tryptanthrin derivatives as Toxoplasma gondii inhibitors--structure-activity-relationship of the 6-position.

P. Grundt, Bogdana Krivogorsky, Amber C. Nelson, 2013, Bioorganic & medicinal chemistry letters.

BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.

S. Breeden, M. Aceto, C. Neilan, 2005, European journal of pharmacology.

14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profiles.

S. Husbands, J. Lewis, J. Traynor, 2003, Journal of medicinal chemistry.

Opioid binding and in vitro profiles of a series of 4-hdroxy-3-methoxyindolomorphinans. Transformation of a delta-selective ligand into a high affinity kappa-selective ligand by introduction of a 5,14-substituted bridge.

S. Husbands, J. Lewis, P. Grundt, 2003, Journal of Medicinal Chemistry.

The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor.

A. Newman, P. Grundt, T. Kopajtic, 2004, Bioorganic & medicinal chemistry letters.

rac-(6S)-6-Hydroxy-6-{2-[2-(propan-2-ylidene)hydrazinylidene]propyl}indolo[2,1-b]quinazolin-12(6H)-one

P. Grundt, Bogdana Krivogorsky, Matthew E. Rodstein, 2011, Acta crystallographica. Section E, Structure reports online.

9-O-Ethylberberrubinium iodide monohydrate

P. Grundt, S. M. Berry, Bogdana Krivogorsky, 2010, Acta crystallographica. Section E, Structure reports online.

Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii.

P. Grundt, Bogdana Krivogorsky, K. A. Douglas, 2012, Bioorganic & medicinal chemistry letters.

Proerectile Effects of Dopamine D2-Like Agonists Are Mediated by the D3 Receptor in Rats and Mice

D. Grandy, Shaomeng Wang, R. Sunahara, 2009, Journal of Pharmacology and Experimental Therapeutics.

Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats

A. Newman, P. Grundt, R. Luedtke, 2009, Neuropharmacology.

Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand.

E. Robinson, D. Nutt, A. Hudson, 2000, Bioorganic & medicinal chemistry letters.

Formation of tryptanthrin compounds upon Oxone-induced dimerization of indole-3-carbaldehydes

P. Grundt, Amber C. Nelson, Emily S. Kalinowski, 2013 .

N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.

A. Newman, P. Grundt, T. Kopajtic, 2005, Bioorganic & medicinal chemistry letters.

Is the 2,3-carbon-carbon bond of indole really inert to oxidative cleavage by Oxone?--synthesis of isatoic anhydrides from indoles.

P. Grundt, Amber C. Nelson, Nikolas J. Czerniecki, 2013, Organic & biomolecular chemistry.

Annulated ring-systems by domino-heck-aldol-condensation and domino-Heck-Michael-addition processes

P. Grundt, G. Dyker, 1996 .

Construction of the Steroid Framework via a Functionalized Macrocyclic Compound

P. Grundt, G. Dyker, 1999 .

Synthesis of Functionalized 4a‐Methyl‐1,2,3,4,4a,9,10,10a‐octahydrophenanthrenes

P. Grundt, G. Dyker, 1999 .

7,9-Dichloro-6H,12H-indolo[2,1-b]quinazoline-6,12-dione

V. Nemykin, P. Grundt, Bogdana Krivogorsky, 2010, Acta crystallographica. Section E, Structure reports online.

Inhibition of Toxoplasma gondii by Indirubin and Tryptanthrin Analogs

R. Yolken, P. Grundt, L. Jones-Brando, 2008, Antimicrobial Agents and Chemotherapy.

Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors

H. Sitte, A. Newman, U. Gether, 2008, Molecular Pharmacology.

Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.

Robert R Luedtke, Peter Grundt, Michelle Taylor, 2007, Bioorganic & medicinal chemistry letters.

Heck Reaction and Robinson-Type Annulation: A Versatile Combination.

P. Grundt, G. Henkel, G. Dyker, 1998, The Journal of organic chemistry.

PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats

Z. Xi, A. Newman, P. Grundt, 2011, Journal of psychopharmacology.

Guanidino N-Substituted and N,N-Disubstituted Derivatives of the κ-Opioid Antagonist GNTI

S. Husbands, J. Lewis, J. Traynor, 2003 .

Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats

A. Newman, P. Grundt, R. Luedtke, 2011, Neuropharmacology.

Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists

Susanta K. Sarkar, Joseph B. Mandeville, Ji-Kyung Choi, 2010, Psychopharmacology.

Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists

Shaomeng Wang, Jianyong Chen, A. Newman, 2007, Psychopharmacology.

Proerectile Effects of Dopamine D2-Like Agonists Are Mediated by the D3 Receptor in Rats and Mice

D. Grandy, Shaomeng Wang, R. Sunahara, 2009, Journal of Pharmacology and Experimental Therapeutics.

Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways

A. Newman, P. Grundt, R. Luedtke, 2010, Synapse.

Food Restriction Alters N′-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (Pramipexole)-Induced Yawning, Hypothermia, and Locomotor Activity in Rats: Evidence for Sensitization of Dopamine D2 Receptor-Mediated Effects

D. Calinski, A. Newman, J. Woods, 2008, Journal of Pharmacology and Experimental Therapeutics.

Cocaine self-administration in dopamine D₃ receptor knockout mice.

A. Newman, P. Grundt, Morgane Thomsen, 2012, Experimental and clinical psychopharmacology.

Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys

M. Nader, A. Newman, P. Grundt, 2011, Neuropsychopharmacology.

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.

Erin E. Carlson, Erin E Carlson, Robert R Luedtke, 2005, Journal of medicinal chemistry.

Dopamine D3 and D2 Receptor Mechanisms in the Abuse-Related Behavioral Effects of Cocaine: Studies with Preferential Antagonists in Squirrel Monkeys

R. Spealman, A. Newman, C. Achat-Mendes, 2010, Journal of Pharmacology and Experimental Therapeutics.

Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.

Ji-Kyung Choi, Robert R Luedtke, Peter Grundt, 2007, Journal of medicinal chemistry.

The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats

Mikhail N. Koffarnus, A. Newman, S. Husbands, 2009, Psychopharmacology.

Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.

A. Newman, P. Grundt, T. Kopajtic, 2004, Journal of medicinal chemistry.

Dopamine D3 and D2 Receptor Mechanisms in the Abuse-Related Behavioral Effects of Cocaine: Studies with Preferential Antagonists in Squirrel Monkeys

R. Spealman, A. Newman, P. Grundt, 2010, Journal of Pharmacology and Experimental Therapeutics.

Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii.

P. Grundt, Bogdana Krivogorsky, K. A. Douglas, 2012, Bioorganic & medicinal chemistry letters.